Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis
- PMID: 26913836
- DOI: 10.1111/vaa.12360
Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis
Abstract
Objective: To evaluate the analgesic efficacy of meloxicam oral transmucosal spray (OTMS) alone and with tramadol in cats with osteoarthritis (OA).
Study design: Randomized, blinded study.
Animals: Fifteen geriatric cats weighing 4.5 ± 1.0 kg.
Methods: Healthy cats with OA were randomly administered a placebo (every 12 hours orally) and meloxicam OTMS (approximately 0.05 mg kg-1 every 24 hours) (group M, n = 7), or tramadol (3 mg kg-1 every 12 hours orally) and meloxicam OTMS (group TM, n = 8) for 25 days. Evaluations performed before treatment (D0) and at week 3 (W3) consisted of peak vertical force, motor activity and response to mechanical temporal summation of pain (RMTS). Data were analyzed with mixed models and Fisher's exact test.
Results: Mean ± standard deviation peak vertical force (percentage of body weight) increased significantly in both groups (p = 0.02), from 47.7 ± 6.5% to 60.5 ± 9.4% in group M, and from 51.8 ± 5.0% to 64.1 ± 6.5% in group TM, with no difference between groups. Motor activity increased in M (from 43 ± 12 to 56 ± 13; p = 0.02), but not in TM. The number of stimulations from RMTS increased in TM only. Cut-off values were reached in a larger number of cats (n = 5) in TM than M (n = 1) (p < 0.05). Gastrointestinal adverse effects were self-limiting in six cats, including five in TM.
Conclusions and clinical relevance: Meloxicam OTMS had similar effects on peak vertical force, motor activity and pain sensitization as previously reported for oral meloxicam in OA cats. The tramadol-meloxicam combination provided no evident benefit over meloxicam alone, except for central hypersensitivity (assessed with RMTS). Further assessment of the potential toxicity of the combination is required prior to clinical use. Gingival administration was well accepted overall.
Keywords: analgesia; degenerative joint disease; feline chronic pain; meloxicam; osteoarthritis; tramadol.
© 2016 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia.
Similar articles
-
Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools.Vet J. 2013 Jun;196(3):360-7. doi: 10.1016/j.tvjl.2013.01.009. Epub 2013 Feb 14. Vet J. 2013. PMID: 23416029 Clinical Trial.
-
Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis.PLoS One. 2017 Apr 12;12(4):e0175565. doi: 10.1371/journal.pone.0175565. eCollection 2017. PLoS One. 2017. PMID: 28403198 Free PMC article. Clinical Trial.
-
Effects of tramadol alone, in combination with meloxicam or dipyrone, on postoperative pain and the analgesic requirement in dogs undergoing unilateral mastectomy with or without ovariohysterectomy.Vet Anaesth Analg. 2013 Nov;40(6):641-9. doi: 10.1111/vaa.12080. Epub 2013 Aug 5. Vet Anaesth Analg. 2013. PMID: 23910901 Clinical Trial.
-
Case studies of compounded Tramadol use in cats.Int J Pharm Compd. 2012 Jan-Feb;16(1):44-9. Int J Pharm Compd. 2012. PMID: 23050310 Review.
-
Osteoarthritis in the cat: 2. how should it be managed and treated?J Feline Med Surg. 2012 Jan;14(1):76-84. doi: 10.1177/1098612X11432829. J Feline Med Surg. 2012. PMID: 22247327 Free PMC article. Review.
Cited by
-
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.Animals (Basel). 2024 Feb 24;14(5):711. doi: 10.3390/ani14050711. Animals (Basel). 2024. PMID: 38473097 Free PMC article.
-
Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats.J Adv Vet Anim Res. 2021 Sep 19;8(3):404-422. doi: 10.5455/javar.2021.h529. eCollection 2021 Sep. J Adv Vet Anim Res. 2021. PMID: 34722739 Free PMC article. Review.
-
Efficacy and Safety of an Anti-nerve Growth Factor Antibody (Frunevetmab) for the Treatment of Degenerative Joint Disease-Associated Chronic Pain in Cats: A Multisite Pilot Field Study.Front Vet Sci. 2021 May 28;8:610028. doi: 10.3389/fvets.2021.610028. eCollection 2021. Front Vet Sci. 2021. PMID: 34124212 Free PMC article.
-
Validation and Characterization of Platelet-Rich Plasma in the Feline: A Prospective Analysis.Front Vet Sci. 2020 Aug 11;7:512. doi: 10.3389/fvets.2020.00512. eCollection 2020. Front Vet Sci. 2020. PMID: 32851053 Free PMC article.
-
Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy.Sci Rep. 2020 Jun 25;10(1):10351. doi: 10.1038/s41598-020-66977-9. Sci Rep. 2020. PMID: 32587280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous